Skip to main content
logo
Formycon AG (ETR:FYB)
Germany flag Germany · Delayed Price · Currency is EUR
24.65
-0.70 (-2.76%)
Aug 13, 2025, 11:43 AM CET

Ligand Pharmaceuticals Revenue

In the year 2024, Formycon AG had annual revenue of 69.67M EUR, down -10.32%. Formycon AG had revenue of 42.78M in the half year ending December 31, 2024, with 72.14% growth.

Revenue
69.67M
Revenue Growth
-10.32%
P/S Ratio
6.42
Revenue / Employee
278.70K
Employees
250
Market Cap
447.60M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202469.67M-8.02M-10.32%
Dec 31, 202377.70M35.20M82.83%
Dec 31, 202242.50M5.88M16.07%
Dec 31, 202136.61M2.32M6.76%
Dec 31, 202034.30M1.14M3.43%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Siemens Healthineers AG23.38B
Merck KGaA21.22B
Bayer Aktiengesellschaft46.17B
Fresenius SE & Co. KGaA22.28B
Sartorius Aktiengesellschaft3.47B
Fresenius Medical Care AG19.52B
Fielmann Group AG2.33B
Carl Zeiss Meditec AG2.18B
Revenue Rankings

Formycon AG News

More News